Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case–control study

BACKGROUND: Recombinant factor VIIa (rFVIIa) may be used for rapid hemostasis in life-threatening hemorrhage. In warfarin-associated intracerebral hemorrhage (wICH), FVIIa use is controversial and may carry significant thromboembolic risks. We compared incidence of baseline thromboembolic risk facto...

Descripción completa

Detalles Bibliográficos
Autores principales: H-Y, Chou Sherry, Xuemei, Cai, G, Konigsberg Rachael, M, Bresette Linda, V, Henderson Galen, A, Sorond Farzaneh, K, Feske Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538560/
https://www.ncbi.nlm.nih.gov/pubmed/23241423
http://dx.doi.org/10.1186/1471-2377-12-158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538560/
https://www.ncbi.nlm.nih.gov/pubmed/23241423
http://dx.doi.org/10.1186/1471-2377-12-158

Ejemplares similares